In addition, Amphiregulin has been shown to increase cardiac fibrosis and aggravate cardiac dysfunction in a mouse model of myocardial infarction (Liu et al, 2018), and promote fibroblast activation in pulmonary fibrosis (Ding et al, 2016; Liu et al, 2016b). Here, AREG is linked to myocardial infarction.